Infant, Premature — Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?
Citation(s)
Arvedson JC, Lefton-Greif MA Anatomy, physiology, and development of feeding. Semin Speech Lang. 1996 Nov;17(4):261-8.
Fucile S, Gisel E, Lau C Oral stimulation accelerates the transition from tube to oral feeding in preterm infants. J Pediatr. 2002 Aug;141(2):230-6. Erratum in: J Pediatr 2002 Nov;141(5):743.
Haxhija EQ, Rosegger H, Prechtl HF Vagal response to feeding tube insertion in preterm infants: has the key been found? Early Hum Dev. 1995 Mar 17;41(1):15-25.
Lau C, Schanler RJ Oral motor function in the neonate. Clin Perinatol. 1996 Jun;23(2):161-78. Review.
Lau C, Smith EO, Schanler RJ Coordination of suck-swallow and swallow respiration in preterm infants. Acta Paediatr. 2003 Jun;92(6):721-7.
Mizuno K, Ueda A The maturation and coordination of sucking, swallowing, and respiration in preterm infants. J Pediatr. 2003 Jan;142(1):36-40.
Pinelli J, Symington A Non-nutritive sucking for promoting physiologic stability and nutrition in preterm infants. Cochrane Database Syst Rev. 2001;(3):CD001071. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD001071.
Simpson C, Schanler RJ, Lau C Early introduction of oral feeding in preterm infants. Pediatrics. 2002 Sep;110(3):517-22.
Stevenson RD, Allaire JH The development of normal feeding and swallowing. Pediatr Clin North Am. 1991 Dec;38(6):1439-53. Review.
Suess PE, Alpan G, Dulkerian SJ, Doussard-Roosevelt J, Porges SW, Gewolb IH Respiratory sinus arrhythmia during feeding: a measure of vagal regulation of metabolism, ingestion, and digestion in preterm infants. Dev Med Child Neurol. 2000 Mar;42(3):169-73. Erratum in: Dev Med Child Neurol 2000 May;42(5):353.
Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
